Hyderabad, India (PressExposure) May 14, 2015 -- The livestock industry has seen steady growth over the past 2 decades or so and the antibiotic market has been growing along with it till 2006. Post 2006 the ban on use of antibiotics as a source of animal feed and the increasing incidence of antibiotic microbes has seen a reduced growth in the antibiotic market, but the rising incidence of coccidiosis over the past 50 years and its impact on the overall cost to benefit ratio for the meat industry has boosted the anticoccidials drug market.
The increase in global population and also in the per capita global consumption of meat, the increased adoption of intensive farming methods is estimated to drive the market for anticoccidials. A change in diet in developing countries is also aiding the growth of the meat industry and hence will help drive the anticoccidials market.
The Asia pacific region is set to be the highest contributor in terms of this market and is set to contribute close to 50% of the total revenue by the year 2020. The countries set to be major contributors from this region are China, India, Japan, Australia etc. The growth in the North American and European markets is set to be stagnant due to the stagnated market and government restrictions.
The Asia Pacific market is the fastest growing market for anticoccidials. This is primarily due to the increased demand for meat proteins in countries like China, India, and Malaysia etc. The increased demand for meat proteins has increased the meat production in the region. China is the leading contributor in this region. The region is characterized by a myriad of small players in the market both for Meat production as well as antimicrobial agent production. This is leading to a price war as these cheap alternatives are giving the multinationals a run for their money.
The Asia Pacific market for anticoccidials has grown at a CAGR of 8.4% from 2012 to 2014 and the growth is expected to continue during the forecasted period. Currently very little regulations are in place leaving the market unorganized and open for competition to enter.
Asia-Pacific and South America are the potential markets of the industry. In the next six years key players of the industry are expected to tap a major share of the Asia-Pacific market. North America and Europe are advanced producers of antimicrobial agents. The Developments and approaches to anticoccidials drugs in these markets are driving change in global market.
The industry is and will continue to face different challenges related to government regulations and Microbial resistance buildup in US and Europe, so the major players will be focusing on the less regulated markets in the Asia Pacific and South America. These being the regions expected to grow the most during the forecasted period. Also the development of Anticoccidial vaccines will add to the growth of the market due to the rising need to find new and improved ways of treating coccidiosis and also because of the rising incidences of resistant organisms developing by the increased prophylactic usage of anticoccidials drugs currently available in the market.